It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2004.
2004 | Chennai, Tamil Nadu, India | ActiveIndu Remedies Private Limited, a active private limited company, was established on 23 November 2004 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51397TN2004PTC054711. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹8.00 M and a paid-up capital of ₹8.00 M.
It upholds a active non-compliant status. Employing 2 professional, Its leadership includes Muthaya Mathivanan (Director), Dinagarajan Mathivanan (Additional Director). Past directors included Sampath Kumar Venugopal Agoramoorthy, Krishnaswamy Kamala, Subhas Chandran. It holds ₹3.08 M open charges and ₹4.29 Cr settled loans. Its latest AGM occurred on 31 December 2020, with the balance sheet filed on 31 March 2020. It is based at D-10, Mugappair Industrial Estate Mugappair West, Chennai, Tamil Nadu, 600037.
U51397TN2004PTC054711
054711
23 November 2004
₹8.00 M
₹8.00 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Indu Remedies Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Muthaya Mathivanan | Director | 29 Jul 2010 | Current |
| Dinagarajan Mathivanan | Additional Director | 24 Oct 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Jul 2013 | Past |
| Pramod Abcsdd | Director | 09 Aug 2010 | Past |
| Pramod Abcsdd | Whole-Time Director | 24 Oct 2017 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2010 | Past |
| Pramod Abcsdd | Director | 12 Jan 2009 | Past |
| Pramod Abcsdd | Director | 12 Jan 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Indu Remedies Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 56.56% decrease. The company also saw a substantial improvement in profitability, with a 86.58% increase in profit. The company's net worth moved up by a moderate rise of 1.07%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Indu Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹3,079,998.00
₹42,881,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 May 2024 | Hdfc Bank Limited | ₹1.81 M | Open |
| 01 Sep 2006 | Central Bank Of India | ₹1.27 M | Open |
| 14 Jun 2018 | Others | ₹2.50 M | Satisfied |
| 05 Sep 2008 | Canara Bank | ₹1.80 Cr | Satisfied |
| 20 Dec 2006 | State Bank Of India | ₹2.24 Cr | Satisfied |
Explore comprehensive loan charge details -
Indu Remedies has a workforce of 2 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Indu Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indu Remedies's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 14 Jun 2018 via Charge ID 100186845 with Others was fully satisfied on 03 Feb 2025. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 1.81 M with Charge ID 100968311 was registered on 24 May 2024. was recorded as a recent event.
The activity Indu Remedies Private Limited last Annual general meeting of members was held on 31 Dec 2020 as per latest MCA records. was completed.
Indu Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2020 with Roc Chennai. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 2.50 M with Charge ID 100186845 was registered on 14 Jun 2018. was completed.
The activity A charge registered on 05 Sep 2008 via Charge ID 10229808 with Canara Bank was fully satisfied on 16 Apr 2018. was completed.
The CIN of Indu Remedies Private Limited is U51397TN2004PTC054711.
Indu Remedies Private Limited is headquartered at D-10, Mugappair Industrial Estate Mugappair West, Chennai, Tamil Nadu, 600037.
Indu Remedies Private Limited was incorporated on 23 November 2004.
The current directors of Indu Remedies Private Limited are
The primary industry of Indu Remedies Private Limited is Manufacturing.
Indu Remedies Private Limited is unlisted.
The authorized capital of Indu Remedies Private Limited is ₹8.00 M, and the paid-up capital is ₹8.00 M.
The compliance status of Indu Remedies Private Limited is Active Non-Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX